期刊文献+

肝癌合并门静脉高压症联合手术治疗的临床研究 被引量:7

原文传递
导出
摘要 肝癌合并肝硬化、门静脉高压症在我国比较常见。目前,虽然在术前安全性综合评估、术中精准肝切除技术、术后肝脏功能恢复和功能衰竭的治疗等方面取得了进展,但是,同期手术处理肝癌合并门静脉高压症的风险仍然较大。2007年以来,我科对39例可切除原发性肝癌合并门静脉高压症患者施行了联合手术治疗,现报告如下。
出处 《中华肝胆外科杂志》 CAS CSCD 北大核心 2013年第8期631-632,共2页 Chinese Journal of Hepatobiliary Surgery
基金 基金项目:常州市卫生局重大科技计划(ZD200704)
  • 相关文献

参考文献4

二级参考文献44

  • 1Zhi-Xin Cao,Xiao-Ping Chen,Zai-De Wu the Hepatic Surgery Center, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.Changes of immune function in patients with liver cirrhosis after splenectomy combined with resection of hepatocellular carcinoma[J].Hepatobiliary & Pancreatic Diseases International,2003,2(4):562-565. 被引量:34
  • 2Leong TY,Leong AS.Epidemiology//Lau WY,ed.Hepatocellular carcinoma.Singapore:World Scientific Publishing Co Pte Ltd,2008:1-24.
  • 3Spiegel BM,Targownik L,Dulai GS,et al.Endoscopic screening for esophageal varices in cirrhosis:is it ever cost-effective? Hepatology,2003,37:366-377.
  • 4Lang BH,Poon RT,Fan ST,et al.Outcomes of patients with hepatocellular carcinoma presenting with variceal bleeding.Am J Gastroenterol,2004,99:2158-2165.
  • 5Amitrano L,Guardascione MA,Bennato R,et al.MELD score and hepatocellular carcinoma identify patients at different risk of short-term mortality among cirrhotics bleeding from esophageal varices.J Hepatol,2005,42:820-825.
  • 6Yeh JL,Peng YC,Tung CF,et al.Clinical predictors of large esophagogastric varices in patients with hepatocellular carcinoma.Dig Dis Sci,2002,47:723-729.
  • 7Primignani M,Carpinelli L,Preatoni P,et al.Natural history of portal hypertensive gastropathy in patients with liver cirrhosis.The New Italian Endoscopic Club for the study and treatment of esophageal varices (NIEC).Gastroenterology,2000,119:181-187.
  • 8Bellis L,Nicodemo S,Galossi A,et al.Hepatic venous pressure gradient does not correlate with the presence and the severity of portal hypertensive gastropathy in patients with liver cirrhosis.J Gastrointestin Liver Dis,2007,16:273-277.
  • 9Bruix J,Sherman M,Llovet JM,et al.Clinical management of hepatocellular carcinoma:conclusions of the Barcelona-2000 EASL conference,European Association for the Study of the Liver.J Hepatol,2001,35:421-430.
  • 10Llovet JM,Bru C,Bruix J.Prognosis of hepatocellular carcinoma:the BCLC staging classification.Seminars in Liver Disease,1999,19:329-338.

共引文献25

同被引文献46

引证文献7

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部